NCT03394105

Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer

Pilot Study to Evaluate the Effect of Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 4 (actual)
• Sponsor: Asan Medical Center · Academic / Other
• Sex: All
• Age: 20 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

In this trial, the effect of intrapleural docetaxel administration using medical pleuroscopywill be evaluated in Lung Cancer patient with malignant effusion.

Detailed description

This study is designed to be pilot, single-center, open-label, single-arm, prospective, phase II trial of patient with NSCLC with pleurla effusion. Approximately 40 patients will be enrolled into the trial, and study will be performed to 31Dec2018 from IRB and Korea: MFDS approval date. Docetaxel will be administed to interpleural space using medical pleuroscopy in malignant effusion with lung cancer. Response evaluation will be done until confiramtion of disease progression.

Conditions

• Pleural Effusion, Malignant
• Non-small Cell Carcinoma

Interventions

Type	Name	Description
DRUG	intrapleural docetaxel administration	intrapleural docetaxel administration using medical pleuroscopy in malignant effusion with lung cancer

Timeline

• Start date: 2016-07-26
• Primary completion: 2018-06-22
• Completion: 2018-06-22
• First posted: 2018-01-09
• Last updated: 2019-03-08

Locations

1 site across 1 country: South Korea